Description
GenJet™ DNA In Vitro
Transfection Reagent for U2OS cells is pre-optimized for transfecting U2OS cells.
The U2OS cell line, originally known as the 2T line, was cultivated from the
bone tissue of a fifteen-year-old human female suffering from osteosarcoma.
Established in 1964, the original cells were taken from a moderately
differentiated sarcoma of the tibia. U2 OS cells exhibit epithelial
adherent morphology and viruses were not detected in the line during
co-cultivation with WI-38 cells or in CF tests against SV40, RSV, or
adenoviruses. Cells are positive for insulin-like growth factor I (IGF-I) and
insulin-like growth factor II (IGF II) receptors and express a number of
antigens, including blood type A, Rh+, HLA A2, Aw30, B12, Bw35, and B40(+/-).
Refer to the following optimal transfection conditions for maximal transfection
efficiency on U2 OS cells. GenJet™ reagent, 1.0 ml, is sufficient for 300 to
600 transfections in 24 well plates or 150 to 300 transfections in 6 well plates.
|
Summary of
Optimal Transfection Conditions:
Confluence on the
day of transfection
Cell culture
conditions
GenJet™ (µl) : DNA (µg) Ratio
Diluent for DNA and Transfection Reagent
Incubation Time to Form GenJet™/DNA
Complex
Presence of Serum/Antibiotics
during Transfection
Change Medium 5 Hours After Transfection
Maximal Efficiency
Transfection
Results:
Reporter Gene
Plasmid
Efficiency (GFP %) |
60~70%
DMEM with 4.5 g/L glucose, 10% FBS
3:1
Serum-free DMEM with 4.5 g/L glucose
15 minutes at RT
Yes
No
48 hours
EGFP
pEGFP-N3 (CMV promoter)
95% |
Storage Condition
Store at 4 °C. If stored properly, the product is stable for 12 months or longer
A Picture Showing Transfection Efficiency of GenJet™ Reagent on U2 OS Cells
GenJet™ reagent is optimized for
U2OS. U2OS cells
were grown per ATCC recommended culture medium and transfected with pEGFP-N3 by
GenJet™. The efficiency was checked 48 hours post transfection
Data Sheet
